ID
31306
Beschreibung
Study ID: 104505 Clinical Study ID: BEX104505 Study Title: Phase II Study of Iodine 131 Anti B1 Antibody for 1st or 2nd Relapsed Indolent B-Cell Lymphomas or B-Cell Lymphomas That Have Transformed to a More Aggressive Histology Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00950755 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: tositumomab Trade Name: Bexxar Study Indication: Lymphoma, Non-Hodgkin Any adverse experience is defined as a new or worsening pre-existing medical condition or complication occurring while on study, regardless of its perceived relationship to the drug. Please record all adverse experiences from the time of study entry through the Week 13 visit.
Stichworte
Versionen (1)
- 12.08.18 12.08.18 -
Rechteinhaber
see clinicaltrials.gov
Hochgeladen am
12. August 2018
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Iodine 131 B1 Antibody for B-Cell Lymphomas NCT00950755
Adverse Experiences
- StudyEvent: ODM
Beschreibung
Adverse Experiences
Alias
- UMLS CUI-1
- C0877248
Beschreibung
Adverse Event; Number
Datentyp
integer
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0237753
Beschreibung
Adverse Event
Datentyp
text
Alias
- UMLS CUI [1]
- C0877248
Beschreibung
Adverse Event; CTC grade
Datentyp
text
Alias
- UMLS CUI [1]
- C2985911
Beschreibung
Adverse event, serious
Datentyp
boolean
Alias
- UMLS CUI [1]
- C1519255
Beschreibung
Adverse event; start date
Datentyp
date
Alias
- UMLS CUI [1]
- C2697888
Beschreibung
Adverse event; end date
Datentyp
date
Alias
- UMLS CUI [1]
- C2697886
Beschreibung
Adverse event; frequency
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0439603
Beschreibung
Adverse event; Therapeutic Measures; Drugs
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0087111
- UMLS CUI [1,3]
- C0013227
Beschreibung
Adverse event; Therapeutic Measures; Other
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0087111
- UMLS CUI [1,3]
- C0205394
Beschreibung
Adverse event; Therapeutic Measures; Other; Specification
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0087111
- UMLS CUI [1,3]
- C0205394
- UMLS CUI [1,4]
- C2348235
Beschreibung
Adverse event; Outcome
Datentyp
text
Alias
- UMLS CUI [1]
- C1705586
Beschreibung
Adverse event; Relationship; Drug
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0439849
- UMLS CUI [1,3]
- C0013227
Beschreibung
Adverse event; Relationship; Disease
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0439849
- UMLS CUI [1,3]
- C0012634
Ähnliche Modelle
Adverse Experiences
- StudyEvent: ODM
C0600091 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
C0439603 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,3])
C0087111 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
C0087111 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
C2348235 (UMLS CUI [1,4])
C0439849 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,3])
C0439849 (UMLS CUI [1,2])
C0012634 (UMLS CUI [1,3])
Keine Kommentare